Stocks and Investing
Stocks and Investing
Wed, April 5, 2023
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
[ Wed, Apr 05th 2023
] - WOPRAI
Yigal Nochomovitz Maintained (APLT) at Strong Buy with Decreased Target to $5 on, Apr 5th, 2023
Yigal Nochomovitz of Citigroup, Maintained "Applied Therapeutics, Inc." (APLT) at Strong Buy with Decreased Target from $23 to $5 on, Apr 5th, 2023.
Yigal, nor any peers, have made any analyst calls on APLT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources